tiprankstipranks
Towa Pharmaceutical Co Ltd (JP:4553)
:4553
Japanese Market
4553
Towa Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4553 full AI Analyst Report?

Towa Pharmaceutical Co (4553) Financial Statements

0 Followers

Towa Pharmaceutical Co Financial Overview

Towa Pharmaceutical Co's market cap is currently ¥169.05B. The company's EPS TTM is ¥106.65; its P/E ratio is 5.05; and it has a dividend yield of 2.14%. Towa Pharmaceutical Co is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 26Mar 25Mar 24Mar 23
Income Statement
Total Revenue¥ 259.59B¥ 273.71B¥ 227.93B¥ 208.86B¥ 165.62B
Gross Profit¥ 94.73B¥ 99.10B¥ 81.38B¥ 72.71B¥ 70.19B
Operating Income¥ 23.24B¥ 23.10B¥ 17.65B¥ 5.51B¥ 18.54B
EBITDA¥ 43.34B¥ 45.94B¥ 35.54B¥ 24.92B¥ 29.49B
Net Income¥ 18.99B¥ 5.25B¥ 16.17B¥ 2.20B¥ 15.91B
Balance Sheet
Cash & Short-Term Investments¥ 45.47B¥ 45.31B¥ 29.65B¥ 24.26B¥ 32.83B
Total Assets¥ 470.82B¥ 475.29B¥ 430.65B¥ 371.35B¥ 332.10B
Total Debt¥ 230.98B¥ 226.74B¥ 202.36B¥ 161.52B¥ 140.70B
Net Debt¥ 185.51B¥ 181.43B¥ 172.71B¥ 137.26B¥ 107.87B
Total Liabilities¥ 299.19B¥ 297.18B¥ 274.76B¥ 234.45B¥ 199.93B
Stockholders' Equity¥ 171.63B¥ 178.10B¥ 155.89B¥ 136.89B¥ 132.17B
Cash Flow
Free Cash Flow¥ -5.33B¥ 8.15B¥ -29.64B¥ -26.19B¥ 10.99B
Operating Cash Flow¥ 23.40B¥ 30.43B¥ 8.21B¥ 2.54B¥ 22.13B
Investing Cash Flow¥ -31.29B¥ -25.66B¥ -40.39B¥ -30.28B¥ -59.73B
Financing Cash Flow¥ 21.57B¥ -6.83B¥ 35.41B¥ 17.48B¥ 46.54B
Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History

Income Statement >

Towa Pharmaceutical Co Debt to Assets

Balance Sheet >

Towa Pharmaceutical Co Cash Flow

Cash Flow >

Towa Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >